{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:40:20Z","timestamp":1790516420737,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":2107,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009425","name":"Landsteiner Foundation for Blood Transfusion Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009425","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1111\/jth.13570","type":"journal-article","created":{"date-parts":[[2016,11,21]],"date-time":"2016-11-21T04:07:55Z","timestamp":1479701275000},"page":"329-340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Enhanced uptake of blood coagulation factor VIII containing immune complexes by antigen presenting cells"],"prefix":"10.1016","volume":"15","author":[{"given":"R.B.","family":"Hartholt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Wroblewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Herczenik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Peyron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"ten Brinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Rispens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Nolte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Slot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.W.","family":"Claassens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Nimmerjahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.S.","family":"Verbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Voorberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.13570_bb0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1750-1172-7-24","article-title":"Past, present and future of hemophilia: a narrative review","volume":"7","author":"Franchini","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"10.1111\/jth.13570_bb0015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/jth.12065","article-title":"Dangerous liaisons: how the immune system deals with factor VIII","volume":"11","author":"Wroblewska","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13570_bb0020","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1182\/blood.V96.2.540.014k20_540_545","article-title":"Molecular analysis of human anti\u2010factor VIII antibodies by V gene phage display identifies a new epitope in the acidic region following the A2 domain","volume":"96","author":"van den Brink","year":"2000","journal-title":"Blood"},{"key":"10.1111\/jth.13570_bb0025","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood.V95.2.558","article-title":"Human antibodies with specificity for the C2 domain of factor VIII are derived from VH1 germline genes","volume":"95","author":"van den Brink","year":"2000","journal-title":"Blood"},{"key":"10.1111\/jth.13570_bb0030","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1365-2141.2008.07232.x","article-title":"IgG subclasses of anti\u2010FVIII antibodies during immune tolerance induction in patients with hemophilia A","volume":"142","author":"van Helden","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13570_bb0035","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1182\/blood-2012-07-444877","article-title":"Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients","volume":"121","author":"Whelan","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.13570_bb0040","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1046\/j.1537-2995.1989.29589284147.x","article-title":"Disappearance of inhibitor to factor VIII in HIV\u2010infected hemophiliacs with progression to AIDS or severe ARC","volume":"29","author":"Ragni","year":"1989","journal-title":"Transfusion"},{"key":"10.1111\/jth.13570_bb0045","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1182\/blood.V92.2.496","article-title":"Mechanism and kinetics of factor VIII inactivation: study with an IgG4 monoclonal antibody derived from a hemophilia a patient with inhibitor","volume":"92","author":"Jacquemin","year":"1998","journal-title":"Blood"},{"key":"10.1111\/jth.13570_bb0050","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/j.1538-7836.2005.01309.x","article-title":"Identification and removal of a promiscuous CD4 + T cell epitope from the C1 domain of factor VIII","volume":"3","author":"Jones","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13570_bb0055","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1111\/j.1538-7836.2007.02762.x","article-title":"T\u2010cell responses over time in a mild hemophilia A inhibitor subject: epitope identification and transient immunogenicity of the corresponding self\u2010peptide","volume":"5","author":"James","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13570_bb0060","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1538-7836.2011.04202.x","article-title":"T\u2010cell responses in two unrelated hemophilia A inhibitor subjects include an epitope at the factor VIII R593C missense site","volume":"9","author":"James","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13570_bb0065","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1182\/blood.V95.4.1324.004k25_1324_1329","article-title":"Prevention and treatment of factor VIII inhibitors in murine hemophilia A","volume":"95","author":"Qian","year":"2000","journal-title":"Blood"},{"key":"10.1111\/jth.13570_bb0070","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1055\/s-0037-1616733","article-title":"Blockade of CD40\/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance","volume":"86","author":"Reipert","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13570_bb0075","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1002\/1521-4141(200009)30:9<2548::AID-IMMU2548>3.0.CO;2-H","article-title":"Role of CD154 in the secondary immune response: the reduction of pre\u2010existing splenic germinal centers and anti\u2010factor VIII inhibitor titer","volume":"30","author":"Qian","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1111\/jth.13570_bb0080","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-0037-1612915","article-title":"Mechanism of the immune response to human factor VIII in murine hemophilia A","volume":"85","author":"Wu","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13570_bb0085","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1182\/blood-2011-08-374645","article-title":"CD4 + T\u2010cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA\u2010DRB1*1501 mice","volume":"119","author":"Steinitz","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.13570_bb0090","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cellimm.2015.11.001","article-title":"Hunting down factor VIII in the immunopeptidome","volume":"301","author":"Hartholt","year":"2016","journal-title":"Cell Immunol"},{"key":"10.1111\/jth.13570_bb0095","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/bjh.12028","article-title":"Immune tolerance in haemophilia: the long journey to the fork in the road","volume":"159","author":"DiMichele","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13570_bb0100","first-page":"315","article-title":"Circulating immune complexes containing anti\u2010VIII antibodies in multi\u2010transfused patients with haemophilia A","volume":"39","author":"Kazatchkine","year":"1980","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/jth.13570_bb0105","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1600-0609.1984.tb02582.x","article-title":"Antigen\u2010antibody complexes in hemophilia","volume":"40","author":"Hilgartner","year":"1984","journal-title":"Scand J Haematol Suppl"},{"key":"10.1111\/jth.13570_bb0110","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1182\/blood.V97.3.669","article-title":"Circulating factor VIII immune complexes in patients with type 2 acquired hemophilia A and protection from activated protein C\u2010mediated proteolysis","volume":"97","author":"Nogami","year":"2001","journal-title":"Blood"},{"key":"10.1111\/jth.13570_bb0115","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1182\/blood-2015-10-675512","article-title":"FVIII\u2010binding IgG modulates FVIII half\u2010life in patients with severe and moderate hemophilia A without inhibitors","volume":"128","author":"Hofbauer","year":"2016","journal-title":"Blood"},{"key":"10.1111\/jth.13570_bb0120","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1182\/blood-2008-08-174987","article-title":"Quantitation of anti\u2010factor VIII antibodies in human plasma","volume":"113","author":"Krudysz\u2010Amblo","year":"2009","journal-title":"Blood"},{"key":"10.1111\/jth.13570_bb0125","doi-asserted-by":"crossref","first-page":"5685","DOI":"10.1007\/s00216-015-8751-x","article-title":"Biomimetic biosensor to distinguish between inhibitory and non\u2010inhibitory factor VIII antibodies","volume":"407","author":"Kocot","year":"2015","journal-title":"Anal Bioanal Chem"},{"key":"10.1111\/jth.13570_bb0130","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1182\/blood-2016-02-701805","article-title":"High\u2010affinity, non\u2010inhibitory pathogenic C1 domain antibodies are present in patients with hemophilia A and inhibitors","volume":"128","author":"Batsuli","year":"2016","journal-title":"Blood"},{"key":"10.1111\/jth.13570_bb0135","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1600-065X.2010.00910.x","article-title":"Antibody\u2010mediated modulation of immune responses","volume":"236","author":"Nimmerjahn","year":"2010","journal-title":"Immunol Rev"},{"key":"10.1111\/jth.13570_bb0140","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1365-2567.2006.02464.x","article-title":"Dendritic cells, but not macrophages or B cells, activate major histocompatibility complex class II\u2010restricted CD4 + T cells upon immune\u2010complex uptake in vivo","volume":"119","author":"de Jong","year":"2006","journal-title":"Immunology"},{"key":"10.1111\/jth.13570_bb0145","first-page":"201","article-title":"Antibodies as natural adjuvants","volume":"382","author":"Heyman","year":"2014","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1111\/jth.13570_bb0150","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nri3582","article-title":"The function of Fc\u03b3 receptors in dendritic cells and macrophages","volume":"14","author":"Guilliams","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/jth.13570_bb0155","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1042\/bj2630187","article-title":"Inhibition of human coagulation factor VIII by monoclonal antibodies. Mapping of functional epitopes with the use of recombinant factor VIII fragments","volume":"263","author":"Leyte","year":"1989","journal-title":"Biochem J"},{"key":"10.1111\/jth.13570_bb0160","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1074\/jbc.270.8.3648","article-title":"The role of cleavage of the light chain at positions Arg1689 or Arg1721 in subunit interaction and activation of human blood coagulation factor VIII","volume":"270","author":"Donath","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13570_bb0165","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1074\/jbc.271.4.1935","article-title":"The sequence GluLys of human blood coagulation factor VIII comprises a binding site for activated factor IX","volume":"271","author":"Lenting","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13570_bb0170","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1182\/blood.V91.7.2347","article-title":"A human alloantibody interferes with binding of factor IXa to the factor VIII light chain","volume":"91","author":"Fijnvandraat","year":"1998","journal-title":"Blood"},{"key":"10.1111\/jth.13570_bb0175","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1074-7613(02)00294-7","article-title":"FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection","volume":"16","author":"Ioan\u2010Facsinay","year":"2002","journal-title":"Immunity"},{"key":"10.1111\/jth.13570_bb0180","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.4049\/jimmunol.1101194","article-title":"The inhibiting Fc receptor for IgG, Fc\u03b3RIIB, is a modifier of autoimmune susceptibility","volume":"187","author":"Boross","year":"2011","journal-title":"J Immunol"},{"key":"10.1111\/jth.13570_bb0185","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/art.38311","article-title":"Fc\u03b3 receptor III and Fc\u03b3 receptor IV on macrophages drive autoimmune valvular carditis in mice","volume":"66","author":"Hobday","year":"2014","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"10.1111\/jth.13570_bb0190","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.4049\/jimmunol.1302337","article-title":"IgG\u2010mediated anaphylaxis to a synthetic long peptide vaccine containing a B cell epitope can be avoided by slow\u2010release formulation","volume":"192","author":"Quakkelaar","year":"2014","journal-title":"J Immunol"},{"key":"10.1111\/jth.13570_bb0195","doi-asserted-by":"crossref","first-page":"12414","DOI":"10.1128\/JVI.00745-12","article-title":"Antibody\u2010independent thrombocytopenia in lactate dehydrogenase\u2010elevating virus\u2010infected mice","volume":"86","author":"Su","year":"2012","journal-title":"J Virol"},{"key":"10.1111\/jth.13570_bb0200","doi-asserted-by":"crossref","first-page":"8","DOI":"10.14440\/jbm.2014.12","article-title":"A stepwise procedure for isolation of murine bone marrow and generation of dendritic cells","volume":"1","author":"Madaan","year":"2014","journal-title":"J Biol Methods"},{"key":"10.1111\/jth.13570_bb0205","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3324\/haematol.2015.137067","article-title":"von Willebrand factor binds to the surface of dendritic cells and modulates peptide presentation of factor VIII","volume":"101","author":"Sorvillo","year":"2016","journal-title":"Haematologica"},{"key":"10.1111\/jth.13570_bb0210","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1111\/j.1538-7836.2012.04860.x","article-title":"Shear stress is required for the endocytic uptake of the factor VIII\u2010von Willebrand factor complex by macrophages","volume":"10","author":"Castro\u2010N\u00fa\u00f1ez","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13570_bb0215","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1160\/TH05-11-0729","article-title":"Recombinant factor VIII and factor VIII\u2010von Willebrand factor complex do not present danger signals for human dendritic cells","volume":"96","author":"Pfistershammer","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13570_bb0220","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1084\/jem.150.3.580","article-title":"Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors","volume":"150","author":"Unkeless","year":"1979","journal-title":"J Exp Med"},{"key":"10.1111\/jth.13570_bb0225","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1182\/blood-2014-08-535328","article-title":"FVIII inhibitors: pathogenesis and avoidance","volume":"125","author":"Astermark","year":"2015","journal-title":"Blood"},{"key":"10.1111\/jth.13570_bb0230","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1053\/j.seminhematol.2015.10.008","article-title":"Advances in the clinical management of inhibitors in hemophilia A and B","volume":"53","author":"Leissinger","year":"2016","journal-title":"Semin Hematol"},{"key":"10.1111\/jth.13570_bb0235","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0140-6736(77)90871-6","article-title":"Massive factor\u2010VIII infusion in haemophiliac with factor\u2010VIII inhibitor, high responder","volume":"2","author":"Brackmann","year":"1977","journal-title":"Lancet"},{"key":"10.1111\/jth.13570_bb0240","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.cellimm.2015.11.008","article-title":"War and peace: Factor VIII and the adaptive immune response","volume":"301","author":"Georgescu","year":"2016","journal-title":"Cell Immunol"},{"key":"10.1111\/jth.13570_bb0245","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.4049\/jimmunol.1003412","article-title":"Antibody\u2010mediated coengagement of Fc\u03b3RIIb and B cell receptor complex suppresses humoral immunity in systemic lupus erythematosus","volume":"186","author":"Horton","year":"2011","journal-title":"J Immunol"},{"key":"10.1111\/jth.13570_bb0250","first-page":"1","article-title":"Deletion or inhibition of Fc gamma receptor 2B (CD32) prevents FVIII\u2010specific activation of memory B cells in vitro","volume":"114","author":"Werwitzke","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13570_bb0255","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1182\/blood-2010-04-280214","article-title":"Cytokine\u2010induced immune complex binding to the high\u2010affinity IgG receptor, Fc\u03b3RI, in the presence of monomeric IgG","volume":"116","author":"Van Der Poel","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.13570_bb0260","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/imr.12332","article-title":"Fc receptor inside\u2010out signaling and possible impact on antibody therapy","volume":"268","author":"Brandsma","year":"2015","journal-title":"Immunol Rev"},{"key":"10.1111\/jth.13570_bb0265","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S1074-7613(02)00287-X","article-title":"Fc\u03b3RI\u2010deficient mice show multiple alterations to inflammatory and immune responses","volume":"16","author":"Barnes","year":"2002","journal-title":"Immunity"},{"key":"10.1111\/jth.13570_bb0270","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/jth.12631","article-title":"The Fc gamma receptor IIa R131H polymorphism is associated with inhibitor development in severe hemophilia A","volume":"12","author":"Eckhardt","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13570_bb0275","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1182\/blood-2014-09-598268","article-title":"Affinity of FVIII\u2010specific antibodies reveals major differences between neutralizing and nonneutralizing antibodies in humans","volume":"125","author":"Hofbauer","year":"2015","journal-title":"Blood"},{"key":"10.1111\/jth.13570_bb0280","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1182\/blood-2012-06-434803","article-title":"The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) combined cohort","volume":"121","author":"Astermark","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.13570_bb0285","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1182\/blood-2015-12-685735","article-title":"Whole\u2010exome sequencing to identify genetic risk variants underlying inhibitor development in severe hemophilia A patients","volume":"127","author":"Gorski","year":"2016","journal-title":"Blood"},{"key":"10.1111\/jth.13570_bb0290","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.str.2008.03.001","article-title":"Crystal structure of human factor VIII: implications for the formation of the Factor IXa\u2010Factor VIIIa complex","volume":"16","author":"Ngo","year":"2008","journal-title":"Structure"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.13570","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.13570","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.13570","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622032494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622032494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.13570","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:16:46Z","timestamp":1761535006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622032494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S1538783622032494"],"URL":"https:\/\/doi.org\/10.1111\/jth.13570","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced uptake of blood coagulation factor VIII containing immune complexes by antigen presenting cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.13570","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}